Alterome Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Conferences Trial results

9 October 2024

Triple meeting 2024 – can Revolution succeed where others stumbled?

The group will present the first clinical data on its KRAS G12D-selective project RMC-9805.

Subscribe to Alterome Therapeutics